Literature DB >> 25248879

The hematocrit value in polycythemia vera: caveat utilitor.

Richard T Silver1, Stefani Gjoni.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 25248879     DOI: 10.3109/10428194.2014.966243

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


× No keyword cloud information.
  5 in total

Review 1.  Polycythemia Vera.

Authors:  Jerry L Spivak
Journal:  Curr Treat Options Oncol       Date:  2018-03-07

2.  Time for revival of the red blood cell count and red cell mass in the differential diagnosis between essential thrombocythemia and polycythemia vera?

Authors:  Hans Carl Hasselbalch
Journal:  Haematologica       Date:  2019-11       Impact factor: 9.941

Review 3.  Hepcidin agonists as therapeutic tools.

Authors:  Carla Casu; Elizabeta Nemeth; Stefano Rivella
Journal:  Blood       Date:  2018-03-09       Impact factor: 22.113

4.  Distinguishing essential thrombocythemia JAK2V617F from polycythemia vera: limitations of erythrocyte values.

Authors:  Richard T Silver; Spencer Krichevsky
Journal:  Haematologica       Date:  2019-04-04       Impact factor: 9.941

5.  Alterations to cavefish red blood cells provide evidence of adaptation to reduced subterranean oxygen.

Authors:  Tyler E Boggs; Jessica S Friedman; Joshua B Gross
Journal:  Sci Rep       Date:  2022-03-08       Impact factor: 4.996

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.